• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 POWERPORT SLIM IMPLANTABLE PORT, GROSHONG SINGLE-LUMEN, 8F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 POWERPORT SLIM IMPLANTABLE PORT, GROSHONG SINGLE-LUMEN, 8F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Catalog Number 1718500
Device Problems Fluid/Blood Leak (1250); Device Appears to Trigger Rejection (1524); Material Split, Cut or Torn (4008)
Patient Problems Unspecified Infection (1930); Swelling/ Edema (4577); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 12/28/2023
Event Type  Injury  
Manufacturer Narrative
H10: as the lot number for the device was provided, a review of the device history records is currently being performed.The return of the sample is pending.The investigation of the reported event is currently underway.H10: d4 (expiration date: 08/2021).H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device pending return.
 
Event Description
It was reported that sometime post a port placement in the left side of chest, the patient allegedly experienced a port pocket infection.It was further reported that the port allegedly leaked and the pustulous liquid oozed from the port access site.Furthermore, it was also reported that sometime ago, the patient allegedly had fibrin buildup issue and was given clot busters to treat fibrin issue.Reportedly, patient was provided antibiotics to treat port infection and has cleared up.The current status of the patient is unknown.
 
Event Description
It was reported that sometime post a port placement in the left side of chest, the patient allegedly experienced a port pocket infection, bruising, and swelling around the port site.It was further reported that the port allegedly leaked and the pustulous liquid oozed from the port access site.Furthermore, it was also reported that sometime ago, the patient allegedly had fibrin buildup issue and was given clot busters to treat fibrin issue.Reportedly, patient was provided with antibiotics to treat port infection and has cleared up.The port was removed.The current status of the patient is unknown.
 
Manufacturer Narrative
Manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this product and lot.Investigation summary: one powerport implantable port attached to a groshong catheter was returned for evaluation.Functional, gross visual, tactile and microscopic visual evaluations were performed.Multiple splits were noted throughout the port septum.Hydrostatic pressure was applied by clamping the distal end of the catheter while infusing to observe for leaks; leaks from the port septum were observed.Therefore the investigation is confirmed for the reported leak and identified material split, cut /torn issues.However the investigation is inconclusive for the reported fibrin buildup issue as the reported event cannot be confirmed from the returned sample.The definitive root cause could not be determined based upon available information.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.(expiration date: 08/2021) (method, result, conclusion) section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERPORT SLIM IMPLANTABLE PORT, GROSHONG SINGLE-LUMEN, 8F
Type of Device
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key18562296
MDR Text Key333456046
Report Number3006260740-2023-06155
Device Sequence Number1
Product Code LJT
UDI-Device Identifier00801741026812
UDI-Public(01)00801741026812
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K081311
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 04/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1718500
Device Lot NumberRECR1442
Was Device Available for Evaluation? Device Returned to Manufacturer
Initial Date Manufacturer Received 12/28/2023
Initial Date FDA Received01/23/2024
Supplement Dates Manufacturer Received05/20/2024
Supplement Dates FDA Received05/21/2024
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
-
-